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ABSTRACT 
Background: To examine trends in glaucoma surgery in Australian public hospitals over the 
17-year period between 2001 to 2018.  
Design: Retrospective audit 
Methods: The Australian Institute of Health, Welfare and Ageing hospitalisation database 
was used to review of the total numbers of glaucoma surgeries performed from 2001 to 2018 
in Australian public hospitals.  
Results: Although there was an increase in the absolute number of trabeculectomy 
procedures from 2,926 to 3,244 over the 17-year study period, this represented a gradual 
decline in the age- and gender-standardised number of trabeculectomy procedures from 
15.1 to 13.2 procedures per 100,000 persons. However, during this same period, there was 
a dramatic increase in the number of aqueous shunt insertions from 119 to 3,262 
procedures, representing an age- and gender-standardised increase from 0.6 to 13.3 
procedures per 100,000 persons. Negative binomial regression analysis revealed a 
decrease in trabeculectomy procedures of 1.1% per year, whilst there was increase in tube 
shunt insertions of 16.3% per year (p<0.001 for both). When stratified by age group, there 
was a statistically significant interaction in both trabeculectomy and tube shunt rates by age 
groups over time (p<0.001 for both). Trabeculectomy procedures decreased in those aged > 
60years, compared to stable or increasing rates at younger age groups. Tube shunt 
insertion rates demonstrated a progressively greater increase in older age groups.  
Conclusion and Relevance: Our findings demonstrate a changing trend in the surgical 
management of advanced glaucoma in recent years likely reflecting updated evidence 
regarding the role of tube shunt surgeries.  
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INTRODUCTION 
Glaucoma is the leading cause of irreversiblepreventable blindness in the developed world, 
with an estimated prevalence of 3% in Australians aged over 49 and modelling suggests this 
figure will only increase in coming decades.1,2  Trends in glaucoma management within 
Australia have been previously studied by three audits. Most recently, Newman and Andrew 
studied prescribing patterns and surgical procedures performed in the private health system 
over the 15-year period between 2003 and 2017.3 Two older studies examined similar trends 
between 1994 to 2003, and 1994 to 2014.4,5  In recent years there have been significant new 
developments in treatment strategies for glaucoma patients including newer topical agents, 
increased evidence surrounding the use of laser trabeculoplasty, as well as the growing 
number of minimally invasive glaucoma surgery (MIGS) devices.6 However, despite the 
increasing popularity of MIGS surgery, the majority of currently available devices addresses 
only mild-to-moderate glaucoma, and long-term follow-up remains limited.7 As such, the 
majority of severe, progressive glaucoma is still managed surgically with either 
trabeculectomy or tube shunts.  
 
Australia’s public health system provides universal healthcare with no out-of-pocket 
expenses free of charge to all citizens and is jointly funded by the federal and state 
governments. A proportion of Australians also elect to pay for private health care, whereby 
various costs are incurred by the patient, with subsidies provided by the federal government 
in the form of Medicare rebates. Private health care packages vary in coverage, with 
ophthalmic surgery usually requiring the most expensive, top-tier level of cover. The 
proportion of Australians with private health insurance has also steadily decreased over 
recent years, dropping to 44.2% in 2019.  PAll three previous studies on various trends in 
glaucoma surgery within Australia have utilised data derived from the private health care 
system and as such, are missing the majority of patients who are treated in the public health 
system.3-5 We thus sought to analyse the trends in various glaucoma surgeries performed in 
the public health system using data from the Australian Institute of Health, Welfare and 
Commented [RC2]: Cataract is most common cause of 
preventable blindness 
Commented [RC3]: I would personally move this bit to the 
first paragraph of the Discussion. 
Formatted: Superscript
Ageing (AIHW) to supplement existing studies and provide a more comprehensive analysis 
of surgical treatment of glaucoma in Australia. 
METHODS 
We performed a retrospective data review of the total numbers of glaucoma surgeries 
performed over the 17-year period between 2001 to 2018 in the Australian public healthcare 
system using the AIHW procedure cubes. The procedural data from the AIHW areis derived 
from the National Hospital Morbidity Database, which each state and territory within 
Australia contributes. The data areis derived from all public hospitals within Australia, and 
the proportion of missing data is negligible, representing <0.004% of cases per year.8,9 The 
database collects the following information: type of procedure, year of procedure, patient 
gender, age group, and type of admission (either day or overnight admission). Procedure 
type is classified according to the second edition of the International Statistical Classification 
of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-
AM) and the 3rd to 6th editions of Australian Classification of Health Interventions (ACHI).  
 
Procedural data included for this analysis included those classified under ‘procedures for 
glaucoma’ and included: ‘42746-04 trabeculectomy’, ‘42752-00 insertion of aqueous shunt’, 
‘42749-00 revision of scleral fistula’, ‘42746-05 other filtering (fistulisation) procedures for 
glaucoma not elsewhere classified’, ‘42758-00 goniotomy’ and ‘42770-00 destruction of 
ciliary body’. Procedural data for ‘42698-07 phacoemulsification of crystalline lens’ was also 
collected for comparison.  
 
Australian estimated resident population was obtained using online yearly estimates from 
the Australian Bureau of Statistics.10 A population-adjusted number of procedures performed 
per 100,000 persons was performed to account for yearly increases in population size using 
the formula: (absolute numbers of procedures for year X/estimated resident population for 
year X) x 100 000. We calculated the rates of various surgical procedures including 
trabeculectomy, tube shunt procedures and phacoemulsification of crystalline lens. The total 
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number of trabeculectomy and tube shunt procedures were calculated in 20-year age groups 
(<20, 20-39, 40-59, 60-79 and >80) and the procedure rates were directly standardised 
using the age and gender structure of the Australian population in each relevant year. 
Trends in the number of surgeries performed per year were assessed using negative 
binomial regression models. In the models, the year was fitted as a continuous predictor, 
and age group, gender and the interaction between age group and gender were included as 
categorical predictors to control for population changes over time. Similarly, negative 
binomial regression models were used to assess if time trends in trabeculectomy and tube 
shunt surgeries varied according to age group. In the model, year (continuous), age group, 
gender and the interaction between age group and year were included as predictors. All 
analyses were conducted using Stata, version 16 and statistical significance set at p < 0.05.  
 
RESULTS 
From 2001 to 2018 the absolute number of procedures performed for glaucoma increased 
from 3,928 to 11,371. Although there was an increase in the absolute number of 
trabeculectomy procedures from 2,926 to 3,244 over the 17-year study period, this 
represented a gradual decline in the age- and gender-standardised number of 
trabeculectomy procedures from 15.1 to 13.2 procedures per 100,000 persons. However, 
during this same period, there was a dramatic increase in the number of aqueous shunt 
insertions from 119 to 3,262 procedures, representing an age- and gender-standardised 
increase from 0.61 to 13.3 procedures per 100,000 persons (Figure 1 and Table 1).  
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Figure 1: Rates of Trabeculectomy and Tube Shunt Surgery from 2001 to 2018 
 
Table 1: Number and Incidence of Trabeculectomy, Tube Shunt and 
Phacoemulsification Surgeries from 2001 to 2018 
Year Trab Tube Phaco  Incidence (per 100,000 Population) 
    Trab Tube  Phaco 
2001 2926 119 121568 15.1 0.6 626.2 
2002 2706 129 131209 13.8 0.7 667.7 
2003 2557 144 140892 12.9 0.7 708.2 
2004 2298 120 144946 11.4 0.6 720.1 
2005 2246 136 159526 11.0 0.7 782.2 
2006 2208 135 165848 10.7 0.7 801.3 
2007 2255 160 168507 10.7 0.8 801.8 
2008 2384 174 180187 11.1 0.8 840.7 
2009 2409 170 189446 11.0 0.8 862.9 
2010 2199 322 197002 10.0 1.5 897.4 
2011 2264 330 195906 10.3 1.5 887.8 
2012 2373 485 206064 10.6 2.2 922.4 
2013 2531 535 211973 11.1 2.4 932.6 
2014 2535 699 206064 11.0 3.0 891.4 
2015 2686 1176 211973 11.3 4.9 891.2 
2016 2773 1348 250912 11.6 5.7 1052.0 
2017 2755 2294 260114 11.2 9.3 1057.5 
2018 3244 3262 268872 13.2 13.3 1092.9 
Relative 
increase* % 
10.9 2641.2 121.2 -12,6 95.5 74.5 
*2018 value minus 2001 value divided by 2001 value multiplied by 100 
 
 
Other filtering procedures increased from 0.86 (n=166) to 2.04 (n=501) per 100,000, 
cyclodiode laser increased from 1.36 (n=264) to 2.13 (n=523) per 100,000, while revision of 
scleral fistula increased from 1.32 (n=256) to 4.16 (n=1021) per 100,000 persons during the 
study period. Goniotomy rates remained at <1 per 100,000 persons (range 8-72 per year) 
until 2015 when minimally invasive glaucoma surgery (MIGS) devices were approved by the 
Therapeutic Goods Administration and began being billed under the same code. Thereafter, 
there was a steep rise to 517 procedures in 2015 (2.15 per 100,000 persons) and increasing 
further to 966 in 2016 (4.05 per 100,000), 2822 in 2017 (11.47 per 100,000) and 2054 in 
2018 (8.35 per 100,000). Phacoemulsification cases increased from 626.2 (n=121,568) to 
1092.9 (n=268,872) per 100,000 persons during this time.  
 
The percentage of patients undergoing trabeculectomy as a day surgery procedure 
increased from 64.6% in 2000 to 87.0% in 2018. The increase in day surgery cases for 
tubes was much higher over the study period, from 28.6% in 2000 to 90.0% in 2018. 
 
Negative binomial regression analysis revealed a decrease in trabeculectomy rate of 1.1% 
annually (incidence rate ratio 0.989, 95% confidence interval (CI) 0.983-0.994), whilst there 
was increase in tube shunt insertion of 16.3% annually (incidence rate ratio 1.163, 95% CI 
1.147-1.179) (p<0.001 for both).  
 
When stratified by age group, negative binomial regression analysis revealed a statistically 
significant interaction in both trabeculectomy and tube shunt rates among age groups over 
time, suggesting temporal trends differed among the age groups (p<0.001 for both, Tables 2 
and 3). While trabeculectomy procedures decreased in those 60-79 and >80 years of age, 
they were stable amongst 40-59, and decreasing amongst <20 and 20-39, years of age 
(Table 2 and Figure 2). In contrast, tube insertion rates demonstrated greater increases in 
progressively older age groups (Table 3 and Figure 2).  When stratified by gender, negative 
binomial regression analysis suggested a possible difference by gender in trabeculectomy 
procedure trends (p=0.052). Amongst females, trabeculectomy procedures decreased by 
1.7% per year (CI 0.976-0.991, p<0.001) as compared to males, where trabeculectomy 
procedures were non-significantly decreasing by 0.1% per year (CI 0.986-1.000, p=0.08). 
There was no significant interaction by gender for tube insertion procedures (p=0.49). 
 








<20 0.992 0.968-1.016 0.519 
20-39 1.001 0.993-1.020 0.357 
40-59 1.011 1.003-1.020 0.003 
60-79 0.979 0.972-0.986 <0.001 
>80 0.973 0.963-0.983 <0.001 
 








<20 1.095 1.066-1.125 <0.001 
20-39 1.078 1.059-1.097 <0.001 
40-59 1.131 1.112-1.151 <0.001 
60-79 1.238 1.209-1.238 <0.001 
>80 1.237 1.201-1.273 <0.001 
 




This study represents the first to analyse trends in glaucoma surgery within the Australian 
public health care system and is the first to report on age and gender characteristics of 
Australian patients. We found a slight decrease (1.14%) in the rate of trabeculectomy over 
the 17-year study period as compared to a dramatic increase in tube shunt insertion of 16% 
annually over the same time period. These trends appeared to vary by age group. 
Trabeculectomy procedures decreased in those aged >60years, compared to stable or 
increasing rates at younger age groups. Tube shunt insertion rates demonstrated a 
progressively greater increase in older age groups. - Finally, trabeculectomy procedures 
appeared to be decreasing by a greater extent in females compared to males, whereas tube 
insertion trends were similar in both genders. These findings demonstrate a changing trend 
in the surgical management of advanced glaucoma in recent years, likely reflecting updated 
evidence regarding the role of tube shunts as per the Tube vs Trabeculectomy studies.11  
 
Traditionally trabeculectomy was preferred over tube shunt surgery, which was previously 
reserved for those with failed trabeculectomy or at high risk of trabeculectomy failure. 
However, changing patterns of practice have since emerged following the Tube Versus 
Trabeculectomy study in 2014 and subsequently the Primary Tube Versus Trabeculectomy 
trial in 2018,11,12 which have supported an expanding role of tube shunt procedures beyond 
refractory glaucoma.13 This evolving practice pattern has been observed worldwide, with 
increasing rates of tube shunt surgeries relative to trabeculectomy found in American, British 
and Canadian studies.14-17 Most recently in United States, from 2008 to 2016 the overall 
number of trabeculectomies performed on fee-for-service Medicare patients decreased from 
25,610 in 2008 to 18,925 in 2016, while there was a 20.2% increase in the number of tube 
shunt surgeries from 11,615 in 2008 to 13,960 in 2016.15 In the United Kingdom, rates of 
trabeculectomy remained relatively stable from 2003 to 2012 at 9.06 to 10.76 per 100,000 
persons, whilst tube shunt insertions increased six-fold from 0.3 per 100,000 in 2012 
compared to 1.88 per 100,000 persons in 2003, with the highest increase in those aged 
older than 60.14 Similarly in Ontario, where trabeculectomy rates remained similar between 
1992 to 2012, tube shunts increased more than five-fold in the same period and represented 
one-third of all glaucoma filtration procedures performed in 2012.16  
 
We found significantly higher rates of tube shunt surgery and a more rapid increase over 
time relative to trabeculectomy when compared to the previous three Australian studies 
which included surgical data from the private health system only. With less than half of all 
Australians holding private health care currently, and variations in health care coverage 
seeing many patients still electing to be treated publicly, the majority of glaucoma surgeries 
in Australia remains incompletely captured using this database alone. This is reflected in the 
significantly lower rates of both trabeculectomy and tube surgeries reported by previous 
studies within the same time period. For example, Newman and Andrew reported only 272 
tube surgeries in 2017 performed privately whilst our data revealed 2,294 tube shunt 
procedures performed in the public health care system for the same year.3 Similarly, Kerr et 
al. reported 1,575 trabeculectomies reimbursed privately in 2014,4 as compared to 2,535 in 
the same year in our study.  Furthermore, the previous studies reported rates of 
trabeculectomy remaining significantly higher than tube insertion in recent years whilst our 
findings demonstrate that trabeculectomy and tube shunt procedures are now being 
performed at equal rates in Australian public hospitals. Newman and Andrew3 reported 
trabeculectomy rates of 8 per 100,000 persons compared to tube shunt insertions at just 1 
per 100,000 in 2017, as compared to our higher but similar rates of trabeculectomy and tube 
shunt surgery of 11.2 and 9.3 per 100,000 persons respectively in the same year. It is 
possible this reflects differing patient demographics treated in the private and public health 
system, with more complex and advanced glaucoma cases referred to tertiary care public 
hospitals.  
 
Recent advancements in MIGS devices have seen a dramatic increase in uptake amongst 
ophthalmologists worldwide.7 In Australia, the availability of MIGS in in public hospitals 
varies significantly and the majority of these procedures are still performed privately. Initially 
the use of MIGS was billed under the ‘goniotomy’ code until 2017, when a separate item 
number was created for a combined cataract extraction and trans-trabecular MIGS insertion 
and as of May 2020, there is now a standalone MIGS insertion code. Although there was a 
significant increase in the number of procedures billed under the ‘goniotomy’ code from 2015 
when MIGS became TGA approved in Australia, rates remained significantly lower than 
those previously reported using private health care data. In 2017 for example, there were 
2822 procedures billed under the ‘goniotomy’ code as compared to 4262 MIGS procedures 
in the same year in Newman and Andrew’s study.3 Furthermore, the separate item code for 
cataract combined with trans-trabecular MIGS device was not reported in the AIHW dataset 
and it is unknown what proportion of the surgeries billed under ‘goniotomy’ were MIGS, 
although prior to 2015, cases were stable at <100/year. Our findings suggest that the 
majority of glaucoma surgery presently performed in Australian public hospitals are still 
trabeculectomy and tube shunt procedures, but it would be important to review these trends 
in another few years to determine uptake of MIGS in Australian public hospitals.  
 
As a comparison, we also analysed overall rates of cataract surgery during the same time 
period using the code for ‘phacoemulsification of crystalline lens’ and found a steady 
increase over the same time period, as compared to a decline in trabeculectomy and 
dramatic increase in tube shunt surgeries. This likely reflects increasing demand for public 
health services to the high incidence of cataract development amongst the increasing ageing 
population of Australia,18 with similar increases found in the United States and United 
Kingdom.19,20 Although the literature regarding effect of cataract surgery on intraocular 
pressure in patients with open-angle glaucoma remains mixed,21,22 evidence does suggest 
that cataract surgery does appear to lower intraocular pressure in early glaucoma patients.23 
Furthermore, with the increasing popularity of trans-trabecular MIGS devices often combined 
with cataract surgery aimed at preventing progression of mild to moderate glaucoma, it will 
be interesting to investigate how this trend then affects future rates of trabeculectomy and 
tube shunt procedures. With modelling suggesting that Australia’s ageing population will 
result in significantly higher rates of glaucoma over the next several decades,2 the economic 
impact of various ophthalmic interventions to address the burden of visual impairment in 
Australia’s population will become increasingly important.    
 
Although our study provides valuable information regarding the surgical management of 
glaucoma in Australian public hospitals previously not reported, our results should be taken 
together with previous studies of practice patterns within the private health care system.3-5 
Limitations of our study include the reliance on diagnostic coding, which could have 
contributed to under- or overestimation for certain procedural codes. Furthermore, as our 
data relied on hospital admission data, procedures performed in outpatient treatment rooms 
were not captured, and this is particularly relevant for cyclodiode laser, which is now 
increasingly performed in an outpatient setting and thus our reported numbers are unlikely to 
represent actual rates of cyclodiode performed in Australian public hospitals. Our study also 
lacked specific patient-, hospital- and state-specific information which might have provided 
additional insights into the observed trends.   
 
In summary, our study demonstrates changing trends in the surgical management of 
glaucoma within Australian public hospitals, with tube shunt insertion now performed as 
frequently as trabeculectomy in recent years. These trends are likely to change further with 
the increased uptake of MIGS, as well as improved early detection and non-surgical 
management of glaucoma. 
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